Associated Papers
Advancements in the research of the structure, function, and disease-related roles of ARMC5.
Qu Y et al.
Frontiers of Medicine, 2025
ARMC5 mutations in primary bilateral macronodular adrenal hyperplasia: a family case report.
Wang Y et al.
Bmc Medical Genomics, 2025
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update.
Bouys L et al.
Orphanet Journal of Rare Diseases, 2025
ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humans.
Luo H et al.
Genome Biology, 2024
Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease.
Cavalcante IP et al.
Nature Reviews. Endocrinology, 2022
ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors.
Okuno Y et al.
Jci Insight, 2022
Whole-genome sequencing revealed armadillo repeat containing 5 (ARMC5) mutation in a Chinese family with ACTH-independent macronodular adrenal hyperplasia.
Zhang Q et al.
Endocrine Journal, 2018
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
Drougat L et al.
European Journal of Endocrinology, 2015
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.
Espiard S et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia.
Gagliardi L et al.
The Journal of Clinical Endocrinology and Metabolism, 2014
ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.
Assié G et al.
The New England Journal of Medicine, 2013
Select a paper to view details